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ABSTRACT 
The aim of present work was to evaluate safety & anti- urolithiatic property of various polyherbal formulations using ethylene 
glycol-ammonium chloride & potassium oxonate induced urolithiasis in rats & mice and to evaluate and to evaluate effect of poly 
herbal formulation on oxidative stress, i.e. SOD, catalase, LPO and to evaluate of poly herbal formulation on physical parameter 
i.e. body weight, urine PH, urine volume 
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INTRODUCTION: 
Kidney stone, also called as urolithiasis, when solid 
part or stone present in urinary track. When urine is 
supersaturated by salt, ions and minerals like calcium 
oxalate, Cystine, struvite and uric acid caused renal 
stone. Calcium have highest amount (60- 80 %) in 
stone. They have different size like small to large stone 
(staghorn stone).  In some cases CaOx precipitation 
present in LOH membrane, its accumulate in renal 
papillae’s sub epithelial space, it caused Randall's 
plaques. Symptoms of stone produces when it migrates 
down to urinary track or stay at same position. Various 
studies show that preliminary reason for stone formation 
is calcium phosphate cell which produces Nano bacteria. 
When low volume of urine, high amount of calcium 
excretion or both of this cause supersaturation of CaOx 
in urine lead to kidney stone
1
.  When absorption of 
oxalate in intestine rise (enteric hyperoxaluria), higher 
oxalate contain meal intake, oxalate synthesis altered by 
genetic abnormalities (primary hyperoxaluria-1 and 2) 
and dysfunction of transport mechanism in renal part. 
Although, main reason for urine supersaturation is 
genetic abnormalities bonded to calcium outcome and 
also pH, this phenomena is the main core reason of 
the urolithiasis. In stone formation, growth and crystal-
membrane interaction, protein has main function in 
matrix and organic matrix of stone. World’s 10% of 
population are suffering from urolithiasis because of 
industrialized part effect. Kidney stones are common in 
industrial countries with a yearly frequency of 1 % to 2 
%. Diet plan, Urine alkalinisation method, Analgesic 
drugs, Diuretics, Lithotripsy methods, Allopurinol and 
various Surgery basic steps for curing of CaOx and uric 
acid type stone. Commonest side effects of management 
are hypersensitivity, headache, GIT abnormalities and 
nausea. Acute trauma, bruising & damage to blood 
vessel of the kidney are side effect of ESWL. Herbal 
medicines are moderately safer compared to the 
allopathic medicines. In case of Allopathic medicines 
the gap between ED50 & LD50 is very low while 
comparing with the herbal medicines.  Key objectives 
of herbal medicine management are cure without any 
adverse or side effects. Ayurveda has listed herbal 
medicines to cure or prevention of kidney stone  
diseases  (mutrashmari)  example  like,  Tribulus  
Terrestris  (Gokshrua),  Crataeva Nurvala  (Varuna  
Tree),  Boerhaavia  Diffusa  (Punarnava),  Hordeum  
vulgare  (Barely), Bergenia Ligulata (Pashanbheda), 
Asparagus racemosus (Shatamull), Crataeva religiosa 
(Bidasi), and Dolichos Biflorus (Kulthi). Our primary 
objective of study is to determine anti- urolithiatic 
property of polyherbal formulation on rats & mice
2
. 
MATERIALS AND METHODS: 
Materials Ethylene glycol (EG) 0.75% (v/v), 
Ammonium chloride 1% (w/v) and Potassium oxonate 
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Method Acute oral toxicity study of polyherbal 
formulations was carried out according to OECD 425 
guideline in mice. Two methods were used to check 
anti-urolithiatic effect of polyherbal formulations i.e. 
Ethylene glycol (EG) 0.75% (v/v) uric acid, oxalates. 
Ammonium chloride 1% (w/v) and Potassium oxonate 
induced urolithiasis in rats and mice. Ammonium 
chloride was given first seven days continuously with 
ethylene glycol to accelerate process of renal stone 
formation. EG  was  continued  for  28  days  in  all  
groups  except  normal  control  group.  5 various 
polyherbal formulations were treated in groups 3-7 
and group -8 received standard drug. Blood and urine 
were collected at 14
th
 & 28
th
 days in order to measure 
serum creatinine, uric acid, potassium, chloride, 
phosphorus, calcium, chloride and urine volume, pH, 
uric acid, oxalate, potassium, chloride, calcium, 
phosphate & oxalate. Second animal model employed 
to check anti-urolithiatic effect was Potassium oxonate 
induced hyperuricemia in mice. Potassium oxonate (250 
mg/kg, p.o.) was given to all groups excluding normal 
control group. Polyherbal formulations were treated 60 
minutes after potassium oxonate for consecutive 7 days 
in groups 4-7 and group-8 received standard drug. On 
8
t h
 day blood and urine were collected in order to 
measure water & food intake, serum creatinine, uric 
acid, urine volume, pH 3-5. 
 
RESULTS AND DISCUSSIONS: 
Table 1: Urolithiasis induce by Ethylene Glycol a n d  Ammonium Chloride in Rats 
Result of Body Weight 
 Normal 
 
Control 
Diseases 
 
Control 
Calcirex 
 
Capsule 
Calcirex 
 
Syrup 
Cistonil 
 
Capsule 
Cistonil 
 
syrup 
Cistonil 
 
Tablet 
Standard 
0 week 173.8±8 173.0±8 172.8±7 174.3±5 172.3±9 177.7±9 178.0±8 172.7±6 
1st week 175.8±7 163.8±6 173±8 142.7±10 135±7 149.3±7 176.5±6 168.8±6 
2nd week 188.7±8 177.7±6 172±18 167.3±10 164.3±6 174±11 195.8±6 190.2±7 
3rd week 209.5±9 209.5±4 170±29 199.2±9 199±9 210.2±12 213±36 213±5 
4th week 228.3±10 223.16±5 238.3±9 230.2±9 228.6±11 257.2±13 250.±11 240.6±8 
Toxicity study was performed according to OECD 425 guideline.  Polyherbal formulations found safe up to dose of 2000mg/kg 
 
High level of serum calcium, potassium, chloride & 
acidic pH in DC group showed the production of renal 
stone and RTA.  Whereas polyherbal formulations 
decreased serum calcium, potassium, chloride level 
nearer to normal group and made urine pH alkaline. 
Poly herbal formulations showed effect against kidney 
stone, RTA as well as oxidative stress. 
Table 2: Effects on Serum Calcium (mg/dl) 
Group Serum Calcium (mg/dl) 
14th Day 28th Day 
Normal control 5±1 5.5±0.42 
Disease control 16.5±0.5 18.5±0.7
###
 
Calcirex capsule 8.5±0.5 9±0.36
***
 
Calcirex syrup 15±1 15.1±0.6
**
 
Cistonil capsule 15±11 15.6±0.4
**
 
Cistonil syrup 13.5±0.5 15.8±0.8
*
 
Cistonil tablet 10±2 8.3±0.5
***
 
Standard 6.5±1.5 6.6±.33
***
 
 
 
 
 
Table 3: Effects on Serum Creatinine 
Group Serum Creatinine (mg/dl) 
14th Day 28th Day 
Normal 
control 
0.08±0.03 0.111±0.05 
Disease 
control 
1.431±0.11 
1.49±0.13
###
 
Calcirex 
capsule 
0.669±0.13 
0.402±0.05
***
 
Calcirex 
syrup 
0.628±0.09 
0.49±0.08
***
 
Cistonil 
capsule 
1.11±0.24 
0.802±0.1
**
 
Cistonil syrup 1.237±0.03 1.039±0.12
*
 
Cistonil tablet 0.562±0.07 0.462±0.10
***
 
Standard 0.395±0.05 0.325±0.10
***
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Table 4: Effects on Serum Uric Acid 
Group Serum Uric acid (mg/dl) 
14th Day 28th Day 
Normal 
control 
0.8±0.29 1.96±0.21 
Disease 
control 
6.7±0.53 
7.02±0.41
###
 
Calcirex 
capsule 
6.2±0.62 
5.11±0.67
*
 
Calcirex 
syrup 
6.2±0.24 
5.16±0.41
*
 
Cistonil 
capsule 
4.6±0.54 
3.99±0.67
***
 
Cistonil syrup 5.9±0.26 5.87±0.34
ns
 
Cistonil tablet 3.9±0.51 3.28±0.35
***
 
Standard 3.69±0.43 3.24±0.21
***
 
 
Effects on various urine parameters: 
Biochemical parameters (serum: calcium, creatinine, 
phosphate, potassium, chloride), urine analysis 
parameter (urine: pH, volume, calcium, phosphate, 
potassium, chloride, oxalate) found nearer to normal 
range in polyherbal formulation treated groups. So it 
shows polyherbal formulations having effectiveness 
against urolithiasis. 
Our primary motto was to check the effect of various 
poly herbal formulations’ effect on urolithiasis on 
different in-vitro models.  We employed two different 
animal models i.e. Ethylene glycol model and potassium 
oxonate induced urolithiasis. Both models showed 
significant urolithiasis and it was evident by acidic pH 
of urine in DC. So, it was affirmative signal for stone 
formation & also for kidney damage. On other side, 
treatment group showed basic or normal range pH value. 
So, it was proved treatment was worked properly. It can 
be used to treat renal stone (CaOx & Uric acid) & 
kidney damage.As per the acute toxicity study, poly 
herbal formulations were completely safe up to the dose 
of 2000 mg/kg. All animals were survived with purely 
healthy condition. There was no any abnormality or 
other side effect like condition observed. 
CONCLUSION:  
Toxicity study was performed according to OECD 425 
guideline.  Polyherbal formulations found safe up to 
dose of 2000mg/kg. 
Biochemical parameters (serum: calcium, creatinine, 
phosphate, potassium, chloride), urine analysis 
parameter (urine: pH, volume, calcium, phosphate, 
potassium, chloride, oxalate) found nearer to normal 
range in polyherbal formulation treated groups. So it 
shows polyherbal formulations having effectiveness 
against urolithiasis. 
Significant increased level in SOD & Catalase activity 
found & drop in LPO level was observed, which shows 
that polyherbal formulations have anti-oxidant activity. 
As  per  the  result,  we  concluded  that  various  poly  
herbal  formulations  have potential to cure or treat renal 
stone like CaOx as well as uric acid stone & RTA. 
Cistonil tablet & Calcirex capsule were best poly herbal 
formulation among all to use in urolithiasis as treatm
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